
Phathom Pharmaceuticals PHAT
$ 5.45
2.06%
Phathom Pharmaceuticals PEG Ratio | PHAT
Annual PEG Ratio Phathom Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.06 K | 173 | - | - | - | -0.206 | 0.00014 | - | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.06 K | -0.206 | 308 |
PEG Ratio of other stocks in the Biotechnology industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Brickell Biotech
BBI
|
-0.00431 | - | -5.38 % | $ 6.06 M | ||
|
Applied Therapeutics
APLT
|
0.243 | - | - | $ 8.42 M | ||
|
ESSA Pharma
EPIX
|
0.151 | - | - | $ 8.86 M | ||
|
Generation Bio Co.
GBIO
|
-0.476 | - | - | $ 344 M | ||
|
Clearside Biomedical
CLSD
|
-0.00335 | - | - | $ 25.3 M | ||
|
Merus N.V.
MRUS
|
923 | - | - | $ 5.78 B | ||
|
RAPT Therapeutics
RAPT
|
0.059 | - | - | $ 2.36 B | ||
|
Annexon
ANNX
|
0.176 | $ 4.2 | -0.71 % | $ 651 M | ||
|
AbbVie
ABBV
|
21.1 | $ 293.87 | 0.19 % | $ 520 B | ||
|
Alnylam Pharmaceuticals
ALNY
|
-0.955 | $ 151.6 | -3.2 % | $ 19.9 B | ||
|
Galmed Pharmaceuticals Ltd.
GLMD
|
-0.00342 | $ 4.63 | 21.05 % | $ 20 M | ||
|
Avenue Therapeutics
ATXI
|
-0 | - | -52.27 % | $ 4.45 M | ||
|
Axon Enterprise
AXON
|
0.171 | $ 302.6 | -0.19 % | $ 23.6 B | ||
|
Theratechnologies
THTX
|
-0.116 | - | - | $ 83.9 M | ||
|
Liquidia Corporation
LQDA
|
0.000305 | $ 51.37 | 7.31 % | $ 4.42 B | ||
|
CRISPR Therapeutics AG
CRSP
|
0.0973 | $ 45.05 | -9.97 % | $ 4.05 B | ||
|
Scholar Rock Holding Corporation
SRRK
|
-2 | $ 48.48 | -5.96 % | $ 5.56 B | ||
|
Geron Corporation
GERN
|
1.04 | $ 0.96 | -3.71 % | $ 640 M | ||
|
Bristol-Myers Squibb Company
BMY
|
-1.57 | $ 62.8 | 1.06 % | $ 128 B | ||
|
Titan Pharmaceuticals
TTNP
|
-0.00348 | - | -3.76 % | $ 3.47 M | ||
|
Kazia Therapeutics Limited
KZIA
|
5.03 | $ 7.4 | -0.13 % | $ 113 M | ||
|
Celldex Therapeutics
CLDX
|
1.27 | $ 30.68 | -1.81 % | $ 2.04 B | ||
|
CollPlant Biotechnologies Ltd.
CLGN
|
0.00102 | $ 4.0 | -6.76 % | $ 48.8 M | ||
|
Allena Pharmaceuticals
ALNA
|
0.0566 | - | 3.16 % | $ 1.9 M | ||
|
Ligand Pharmaceuticals Incorporated
LGND
|
0.177 | $ 317.26 | 0.99 % | $ 6.14 B | ||
|
Eli Lilly and Company
LLY
|
4.99 | $ 1 432.7 | 1.47 % | $ 1.29 T | ||
|
TCR2 Therapeutics
TCRR
|
-0.373 | - | - | $ 58.1 M | ||
|
Crinetics Pharmaceuticals
CRNX
|
-0.497 | $ 84.95 | 0.13 % | $ 7.99 B | ||
|
TFF Pharmaceuticals
TFFP
|
-0.000577 | - | -60.05 % | $ 125 K | ||
|
Mesoblast Limited
MESO
|
1.3 | $ 14.0 | -3.06 % | $ 16.9 B | ||
|
CorMedix
CRMD
|
0 | $ 5.37 | -2.1 % | $ 387 K | ||
|
Adaptimmune Therapeutics plc
ADAP
|
-0.00126 | - | -15.15 % | $ 60.3 M | ||
|
MannKind Corporation
MNKD
|
2.51 | $ 4.22 | 0.84 % | $ 1.29 B | ||
|
AVEO Pharmaceuticals
AVEO
|
-0.0315 | - | - | $ 521 M | ||
|
MediciNova
MNOV
|
3.01 | $ 1.4 | -4.76 % | $ 68.7 M | ||
|
Merck & Co.
MRK
|
1.18 | $ 147.75 | -0.68 % | $ 370 B | ||
|
Moderna
MRNA
|
0.0169 | $ 250.79 | -6.77 % | $ 97.6 B | ||
|
Axcella Health
AXLA
|
-0.0713 | - | -16.42 % | $ 249 M | ||
|
Dynavax Technologies Corporation
DVAX
|
-0.688 | - | - | $ 2.02 B | ||
|
Intellia Therapeutics
NTLA
|
-0.114 | $ 11.18 | -7.72 % | $ 1.21 B | ||
|
Novartis AG
NVS
|
1.25 | $ 163.39 | -0.18 % | $ 317 B | ||
|
Omeros Corporation
OMER
|
36.6 | $ 17.3 | -1.48 % | $ 1.1 B | ||
|
Oramed Pharmaceuticals
ORMP
|
0.458 | $ 3.97 | -0.75 % | $ 164 M | ||
|
Tyme Technologies
TYME
|
-0.0215 | - | 8.07 % | $ 54 M | ||
|
Puma Biotechnology
PBYI
|
6.48 | $ 8.13 | -3.22 % | $ 407 M | ||
|
PDS Biotechnology Corporation
PDSB
|
3.77 | $ 1.02 | -5.09 % | $ 47.3 M | ||
|
Cyclerion Therapeutics
CYCN
|
-0.0574 | $ 34.99 | 3.77 % | $ 147 M | ||
|
Pfizer
PFE
|
2.76 | $ 29.34 | 0.36 % | $ 167 B | ||
|
Завод ДИОД
DIOD
|
-0.421 | - | - | - | ||
|
PainReform Ltd.
PRFX
|
-0.00083 | $ 0.78 | -4.24 % | $ 505 K |